← Leaderboards
Natasha Y Frank
Brigham And Women'S Hospital
$4,964,719
Attributed
$13,554,958
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,554,958 · 4
VA$0 · 3
By mechanism
R01$6,973,113 · 2
R24$5,912,245 · 1
K08$669,600 · 1
I01$0 · 3
Top collaborators
- Markus H. Frank19 shared
- Bruce R Ksander15 shared
- George F Murphy4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- George F Murphy$7,377,470
- Markus H. Frank$10,452,698
- Gregory L Stahl$14,189,628
- Christine Guo Lian$2,178,309
- Anny Xiaobo Zhou$14,633,236
Others in their field
Top investigators on “Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- David Heimbrook · Leidos Biomedical Research, Inc.$161,931,307
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,044,559
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$70,591,644
- Michelle M Le Beau · University Of Chicago$70,506,423
Research focus
Stem CellsCellsSkinStem Cell TransplantSelf-RenewalIn VitroStem Cell PopulationSuccessTransplantationIn VivoMonoclonal AntibodiesClinically RelevantLaboratoriesNatural RegenerationGenesBaseMouse ModelWomanChronicMediatingSourceInflammationTissuesNovel Strategies
Grant awards (41)
ABCB5-positive stem cells for LSCD therapy$761,966
R01 · FY2025 · EY
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$413,768
R01 · FY2025 · HL
Targeting therapeutic resistance in glioblastoma$0
I01 · FY2025 · VA · contact PI
ABCB5-positive stem cells for LSCD therapy$761,966
R01 · FY2024 · EY
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$405,493
R01 · FY2024 · HL
Targeting therapeutic resistance in glioblastoma$0
I01 · FY2024 · VA · contact PI
ABCB5-positive stem cells for LSCD therapy$801,142
R01 · FY2023 · EY
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$413,768
R01 · FY2023 · HL
Targeting therapeutic resistance in glioblastoma$0
I01 · FY2023 · VA · contact PI
Multipotent ABCB5-positive cell therapeutics for corneal disease$1,176,331
R24 · FY2022 · EY · contact PI
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$433,517
R01 · FY2022 · HL
Multipotent ABCB5-positive cell therapeutics for corneal disease$1,176,331
R24 · FY2021 · EY · contact PI
Multipotent ABCB5-positive cell therapeutics for corneal disease$1,176,331
R24 · FY2020 · EY · contact PI
ABCB5-positive stem cells for LSCD therapy$487,236
R01 · FY2020 · EY
Identification and targeting of colon cancer initiating cells$0
I01 · FY2020 · VA · contact PI
Multipotent ABCB5-positive cell therapeutics for corneal disease$1,176,331
R24 · FY2019 · EY · contact PI
ABCB5-positive stem cells for LSCD therapy$489,489
R01 · FY2019 · EY
Identification and targeting of colon cancer initiating cells$0
I01 · FY2019 · VA · contact PI
Multipotent ABCB5-positive cell therapeutics for corneal disease$1,206,921
R24 · FY2018 · EY · contact PI
ABCB5-positive stem cells for LSCD therapy$491,647
R01 · FY2018 · EY
Identification and targeting of colon cancer initiating cells$0
I01 · FY2018 · VA · contact PI
ABCB5-positive stem cells for LSCD therapy$598,457
R01 · FY2017 · EY
ABCB5-positive stem cells for LSCD therapy$275,698
R01 · FY2017 · EY
Identification and targeting of colon cancer initiating cells$0
I01 · FY2017 · VA · contact PI
ABCB5+ Dermal Stem Cells In Regenerative Wound Healing$0
I01 · FY2017 · VA · contact PI
ABCB5-positive stem cells for LSCD therapy$534,234
R01 · FY2016 · EY
ABCB5-positive stem cells for LSCD therapy$104,732
R01 · FY2016 · EY
ABCB5+ Dermal Stem Cells In Regenerative Wound Healing$0
I01 · FY2016 · VA · contact PI
Identification and targeting of colon cancer initiating cells$0
I01 · FY2016 · VA · contact PI
ABCB5+ Dermal Stem Cells In Regenerative Wound Healing$0
I01 · FY2015 · VA · contact PI
ABCB5+ Dermal Stem Cells In Regenerative Wound Healing$0
I01 · FY2015 · VA · contact PI
ABCB5+ Dermal Stem Cells In Regenerative Wound Healing$0
I01 · FY2015 · VA · contact PI
Identification and targeting of colon cancer initiating cells$0
I01 · FY2014 · VA · contact PI
Identification and targeting of colon cancer initiating cells$0
I01 · FY2013 · VA · contact PI
Identification and targeting of colon cancer initiating cells$0
I01 · FY2012 · VA · contact PI
Identification and targeting of colon cancer initiating cells$0
I01 · FY2011 · VA · contact PI
Myoregenerative Potential of ABCB5+ Progenitors$133,920
K08 · FY2010 · NS · contact PI
Myoregenerative Potential of ABCB5+ Progenitors$133,920
K08 · FY2009 · NS · contact PI
Myoregenerative Potential of ABCB5+ Progenitors$133,920
K08 · FY2008 · NS · contact PI
Myoregenerative Potential of ABCB5+ Progenitors$133,920
K08 · FY2007 · NS · contact PI
Myoregenerative Potential of ABCB5+ Progenitors$133,920
K08 · FY2006 · NS · contact PI